Britain&#x27s King Charles leaves clinic following prostate therapy

Britain’s King Charles leaves the London Clinic with Britain’s Queen Camilla soon after getting cure for an enlarged prostate in London, Britain January 29, 2024.

Hannah Mckay | Reuters

Britain’s King Charles left healthcare facility on Monday soon after a three-night remain subsequent remedy for an enlarged prostate, television footage confirmed.

The king, 75, who was admitted for a planned course of action on Friday, waved at crowds as he headed house from the London Clinic accompanied by his wife Queen Camilla.

He still left several hours immediately after his daughter-in-law, Kate, the Princess of Wales, also still left the identical clinic following her two 7 days restoration from belly operation.

Resource

World

Citi UK CEO: ‘Phenomenal’ market resilience is keeping recession risk at bay — for now

April 28, 2026

Tiina Lee, the CEO of Citi U.K., expects global growth to remain resilient this year, telling CNBC that a “recessionary environment” is “not our base case.” Markets have continued to perform in an orderly way, despite the economic and geopolitical upheaval caused by the Iran conflict, which entered its 60th day on Tuesday, Lee said. […]

World

‘Draconian development’ in Meta-Manus deal draws the line in China’s AI race with the U.S.

April 28, 2026

Manus was hailed by Chinese state media as the “next DeepSeek” soon after its launch in March 2025, months before the startup relocated to Singapore. Cheng Xin | Getty Images News | Getty Images BEIJING — China’s decision to block U.S. tech giant Meta‘s $2 billion acquisition of artificial intelligence startup Manus is being seen […]

World

Novartis CEO warns reality of Trump’s drug pricing policy will set in over ‘the next 18 months’

April 28, 2026

Novartis‘ CEO warned Tuesday that the U.S. drug pricing policy under President Donald Trump poses a “very difficult situation” and the reality will soon catch up with both drugmakers and patients. “The longer-term implications are significant,” CEO Vas Narasimhan told CNBC’s Carolin Roth. Novartis is focused on getting European and Japanese governments to quickly change […]